The revenue stands at ₹4,197.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.07 per cent from ₹3,303.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.84 per cent.
Operating Profit stands at ₹1,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.67 per cent from ₹1,078.00 crore. This corresponds to a year-on-year *(YoY) growth of 37.23 per cent.
PBDT stands at ₹1,037.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.67 per cent from ₹1,020.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.75 per cent.
Profit Before Tax stands at ₹529.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.01 per cent from ₹814.00 crore. This corresponds to a year-on-year *(YoY) decline of 20.45 per cent.
Net Profit stands at ₹364.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.68 per cent from ₹635.00 crore. This represents a 26.91 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | -2.66% | -3.32% | 5.45% | 1.12% | 18.31% | 39.26% |
| Sun Pharma.Inds. | -0.18% | 0.02% | 1.85% | 5.07% | 1.87% | 9.73% |
| Divi's Lab. | -0.90% | -0.34% | 3.55% | 5.20% | 4.90% | 1.88% |
| Cipla | -0.12% | 0.22% | 8.14% | 4.79% | -7.04% | -3.30% |
| Zydus Lifesci. | 1.69% | 2.91% | 23.85% | 21.77% | 17.93% | 18.76% |
| Dr Reddy's Labs | -0.37% | -1.34% | -0.66% | 1.51% | 4.30% | 4.99% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta